Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

HKG/1177 stock hub

HKG/1177 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/1177is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

96.9B

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/1177

In the news

Latest news · HKG/1177

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E18.8

P25 11.7P50 18.9P75 41.4

Trailing P/E37.6

P25 10.7P50 17.9P75 38.5

ROE12.5

P25 -14.7P50 2P75 9.4

ROIC13.7

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/1177 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

243

Groups with data

Currency

CNY

Showing 243 of 243 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	HK
Employees	21,435
Employees Change	-2,944%
Employees Change Percent	-12.08
Enterprise value	HKD 101.9B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Isin	KYG8167W1380
Last refreshed	2026-05-10
Market cap	HKD 96.9B
Price	HKD 5.43
Price currency	HKD
Rev Per Employee	1,652,705.6x
Sector	Healthcare
Sic	2834
Symbol	hkg/1177
Website	https://www.sbpgroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.69%
EV Earnings	39.09x
EV/EBIT	14.92x
EV/EBITDA	12.75x
EV/FCF	11.37x
EV/Sales	2.88x
FCF yield	9.25%
Forward P/E	18.81x
P/B ratio	2.07x
P/E ratio	37.59x
P/S ratio	2.74x
PE Ratio10 Y	23.64x
PE Ratio3 Y	25.24x
PE Ratio5 Y	25.52x
PEG ratio	0.94x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	19.76%
EBITDA Margin	22.79%
FCF margin	25.3%
Gross margin	82.07%
Gross Profit	HKD 29.1B
Gross Profit Growth	4.53%
Gross Profit Growth3 Y	6.09%
Gross Profit Growth5 Y	3.94%
Net Income	HKD 2.6B
Net Income Growth	-33.04%
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Net Income Growth3 Y	-9.97%
Net Income Growth5 Y	-1.63%
Pretax Margin	21.81%
Profit Margin	7.36%
Profit Per Employee	HKD 121,656
Profitable Years	27
ROA	5.56
Roa5y	5.46
ROCE	12.38
ROE	12.53
Roe5y	20.73
ROIC	13.68
Roic5y	13.79

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	9.87%
Cagr15y	14.57%
Cagr1y	43.77%
Cagr20y	19.14%
Cagr3y	10.6%
Cagr5y	-5.68%
Div CAGR10	19.19%
Div CAGR3	-9.14%
Div CAGR5	2.38%
EPS Growth	-32.13
EPS Growth Quarters	2
EPS Growth Years	0
EPS Growth3 Y	-9.25
EPS Growth5 Y	1.32
FCF Growth	42.41%
FCF Growth3 Y	14.43%
FCF Growth5 Y	9.91%
OCF Growth	40.46%
OCF Growth10 Y	10.67%
OCF Growth3 Y	14.01%
OCF Growth5 Y	8.2%
Revenue Growth	10.28x
Revenue Growth Quarters	2x
Revenue Growth Years	3x
Revenue Growth3 Y	5.65x
Revenue Growth5 Y	4.11x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 0.45
Assets	HKD 84.6B
Cash	HKD 25.6B
Current Assets	HKD 39.7B
Current Liabilities	HKD 29B
Debt	HKD 17.9B
Debt EBITDA	HKD 2.19
Debt Equity	HKD 0.38
Debt FCF	HKD 2
Equity	HKD 46.8B
Interest Coverage	22.6
Liabilities	HKD 37.8B
Long Term Assets	HKD 44.9B
Long Term Liabilities	HKD 8.7B
Net Cash	HKD 7.7B
Net Cash By Market Cap	HKD 7.91
Net Cash Growth	34.93%
Net Debt EBITDA	HKD -0.95
Net Debt Equity	HKD -0.16
Net Debt FCF	HKD -0.86
Tangible Book Value	HKD 30B
Tangible Book Value Per Share	HKD 1.68
WACC	6.76

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.37
Inventory Turnover	2.47
Net Working Capital	HKD -5.9B
Quick ratio	1.23
Working Capital	HKD 10.3B
Working Capital Turnover	HKD 4.92

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.3%
Dividend Growth	12.5%
Dividend Growth Years	1%
Dividend per share	HKD 0.1
Dividend Years	25
Dividend Yield	1.84%
Ex Div Date	2026-06-24
Last Dividend	HKD 0.05
Payout Ratio	64.12%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	156.24%
1Y total return	43.74%
200-day SMA	6.91
3Y total return	35.28%
50-day SMA	5.89
50-day SMA vs 200-day SMA	50under200
5Y total return	-25.35%
All Time High	11.24
All Time High Change	-51.69%
All Time High Date	2020-07-22
All Time Low	0.01
All Time Low Change	62,313.79%
All Time Low Date	2000-10-09
ATR	0.19
Beta	0.64
Beta1y	0.44
Beta2y	0.52
Ch YTD	-12.14
High	5.45
High52	9.12
High52 Date	2025-09-10
High52ch	-40.46%
Low	5.36
Low52	3.74
Low52 Date	2025-05-12
Low52ch	45.19%
Ma50ch	-7.86%
Price vs 200-day SMA	-21.44%
RSI	37.87
RSI Monthly	51.29
RSI Weekly	34.62
Sharpe ratio	0.9x
Sortino ratio	1.63
Total Return	3.14%
Tr YTD	-12.14
Tr15y	669.55%
Tr1m	-14.22%
Tr1w	-0.91%
Tr3m	-16.2%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 7B
Operating Income Growth	9.61
Operating Income Growth3 Y	3.62
Operating Income Growth5 Y	3.16
Operating margin	19.76

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	8,752,857,702%
Net Borrowing	7,304,990,885.4
Shares Insiders	50.95%
Shares Institutions	17.09%
Shares Out	17,844,182,337
Shares Qo Q	0.34%
Shares Yo Y	-1.3%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 8.8B
Average Volume	67,726,756.7x
Bv Per Share	1.91
CAPEX	HKD -1.4B
Ch10y	123.7
Ch15y	525.5
Ch1m	-14.22
Ch1w	-0.91
Ch1y	41.78
Ch20y	2,162.5
Ch3m	-16.2
Ch3y	27.77
Ch5y	-31.78
Ch6m	-20.61
Change	-0.55%
Change From Open	1.12
Close	5.46
Days Gap	-1.65
Depreciation Amortization	1,109,988,170.6
Dollar Volume	294,878,658.7
Earnings Date	2026-05-19
EBIT	HKD 7B
EBITDA	HKD 8.1B
EPS	HKD 0.14
F Score	7
FCF	HKD 9B
FCF EV Yield	8.79x
FCF Per Share	HKD 0.5
Financing CF	4,626,217,050
Fiscal Year End	December
Founded	2,000
Goodwill	4,026,079,770
Graham Number	2.93767
Graham Upside	-45.9
Income Tax	HKD 1.8B
Investing CF	-13,814,157,119
Is Primary Listing	1
Last Earnings Date	2026-03-26
Last Report Date	2025-12-31
Last Split Date	2020-07-20
Last Split Type	Forward
Lynch Fair Value	HKD 0.73
Lynch Upside	-86.54
Ma150	6.61
Ma150ch	-17.83%
Ma20	5.69
Ma20ch	-4.55%
Net CF	1,283,484,181
Next Earnings Date	2026-05-19
Open	5.37
P FCF Ratio	10.81
P OCF Ratio	9.37
Payment Date	2025-09-23
Position In Range	77.78
Ppne	11,784,411,088.1
Price Date	2026-05-08
Price EBITDA	HKD 12
Ptbv Ratio	3.23
Relative Volume	0.78x
Revenue	35,425,744,486x
SBC By Revenue	0.36x
Share Based Comp	129,048,153
Tax By Revenue	5.12x
Tax Rate	23.46%
Tr20y	3,222.48%
Tr6m	-20.61%
Volume	54,305,462
Z Score	2.92

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

HKG/1177 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.8%

$0.10 annual per share

Payout ratio

+64.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+2.4%

1 consecutive years of growth

Total shareholder yield

+3.1%

Next ex-dividend date: 2026-06-24

Performance

HKG/1177 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/1177?

Insider, institutional, and short-interest positioning.

Institutional ownership

+17.1%

Share of float held by funds and institutions

Insider ownership

+50.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-1.3%

Negative means the company is buying back shares.

Technical

HKG/1177 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

37.9

Neutral momentum band

Price vs 200-day MA

-21.4%

50/200-day relationship not available

Beta (5Y)

0.64

Less volatile than the market

Sharpe ratio

0.90

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/1177

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/1177 stock rating?

hkg/1177 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/1177 analysis?

The full report lives at /stocks/hkg/1177/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/1177?

The latest report frames hkg/1177 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/1177 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.